Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial

Family Practice

Volumn 22, Issue 3, 2005, Pages 253-265

  Gattellari, Melina ^a   Donnelly, Neil ^b   Taylor, Nicholas ^c   Meerkin, Matthew ^c   Hirst, Geoffrey ^d   Ward, Jeanette E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c Mayne Health Laverty Pathology   (Australia)

^d Mater Health Services   (Australia)

Author keywords

Informed decision making; PSA screening; Randomised controlled trial

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUSTRALIA; AWARENESS; CANCER SCREENING; CLINICAL LABORATORY; CLINICAL TRIAL; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; CONFLICT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; GENERAL PRACTITIONER; HUMAN; INFORMED CONSENT; MALE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICOLEGAL ASPECT; OUTCOMES RESEARCH; PHYSICIAN ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TELEPHONE;

ADULT; AGED; CLUSTER ANALYSIS; COUNSELING; DECISION MAKING; DIAGNOSTIC TESTS, ROUTINE; FAMILY PRACTICE; FEEDBACK; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PEER REVIEW, HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 19744379788     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/cmi028     Document Type: Article

References (35)

1. National Health Service. Prostate Cancer Risk Management Prostate Cancer Risk Management. http://www.cancerscreening.nhs.uk/prostate/index.html (last accessed May 6 2004).
2. Royal Australian College of General Practitioners (RACGP). Guidelines for preventive activities in general practice. Aust Fam Phys 2001; Special Issue. Also available www.racgp.org.au (last accessed May 6 2004).
3. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 917-929.
4. Smith DP, Armstrong BK. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales. Med J Aust 1998; 169: 17-20.
5. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? J Am Med Assoc 2003; 289: 1414-1420.
6. Pinnock CB, Weller DP, Marshall VR. Self-reported prevalence of prostate-specific antigen testing in South Australia. Med J Aust 1998; 169: 25-28.
7. Ward J, Girgis S. GPs' estimates of men's risk of prostate cancer and screening expectations. Aust New Zealand J Public Health 1999; 23: 219-220.
8. Diefenbach PN, Ganz PA, Pawlow AJ, Guthrie D. Screening by the prostate-specific antigen test: what do the patients know? J Cancer Educ 1996; 11: 39-44.
9. Gattellari M, Young JM, Ward J. GP and patient predictors of PSA screening in Australian general practice. Fam Pract 2003; 20: 289-293.
10. Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians. Arch Fam Med 1997; 6: 453-458.
11. Girgis S, Ward JE, Thomson CJH. General practitioners' perceptions of medicolegal risk. Med J Aust 1999; 171: 362-366.
12. Miller WR, Rollnick S. Motivational Interviewing. (2nd Edition) New York: The Guildford Press; 2002.
13. Prochaska JO, Di Clemente CC. Towards a comprehensive model of change. In Miller WR, Heather N (eds). Treating addictive behaviours: processes of change. New York: Plenum Press; 1986.
14. Ward JE, Girgis S. Making an 'informed decision' about prostate cancer screening: what information is required? Health Prom J Aust 1998; 8: 173-176.
15. Ward J, Young J, Sladden M. Australian general practitioners' views and use of tests to detect early prostate cancer. Aust New Zealand J Public Health 1998; 22: 374-380.
16. Gattellari M, Ward J. Does evidence-based information about prostate cancer screening enhance consumer decision making? A randomised controlled trial. J Med Screening 2003; 10: 27-39.
17. Gattellari M, Ward J. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Education and Counseling. Published online 9 December 2004.
18. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J 1998; 317: 465-468.
19. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Effective Practice and Organisation of Care Group. Cochrane Database of Systematic Reviews. Issue 4, 2002.
20. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Effective Practice and Organisation of Care Group. Cochrane Database of Systematic Reviews. Issue 4, 2002.
21. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Effective Practice and Organisation of Care Group. Cochrane Database of Systematic Reviews. Issue 4, 2002.
22. Bland, JM. Clinstat software, London: St. George's Hospital Medical School, 1998. Available from http://www.sghms.ac.uk/depts/phs/staff/jmb/jmbsoft.htm (last accessed May 6 2004).
23. Norusis JM/SPSS Inc. SPSS for Windows-based system user's guide release 9.0. Chicago; SPSS Inc; 1999.
24. Entwistle VA, Sowden AJ, Watt IS. Evaluating interventions to promote patient involvement in decision-making: by what criteria should effectiveness be judged? J Health Serv Res Pol 1998; 3: 100-107.
25. Young JM, Ward J. Can distance learning improve smoking cessation advice in family practice? J Cont Educ Health Prof 2002; 22: 84-93.
26. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res 1997; 29: 21-43.
27. Degner LF, Sloan HA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 1992; 45: 941-950.
28. Dolan JG. A Method for Evaluating Health Care Providers' Decision Making: The Provider Decision Process Assessment Instrument. Med Decision Making 1999; 19: 38-41.
29. Perneger TV. What's wrong with Bonferroni adjustments. Br Med J 1998; 316: 1236-1238.
30. StataCorp. Stata Statistical Software: release 5.0. College Station, TX: Stata Corporaton; 1997.
31. SAS Institute. SAS Procedures Guide, Version 8.0. North Carolina: SAS Institute; 1999.
32. Murray DM. Design and analysis of group randomized trials. New York: Oxford University Press; 1998.
33. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley; 1981.
34. Grismshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and efficiency of guidelines dissemination and implementation strategies. Health Technology Assessment 2004 8. http://www.hta.nhsweb.nhs.uk/fullmono/mon806.pdf (last accessed May 6 2004).
35. Cockburn J, Ruth D, Silagy C, Dobbin M, Reid Y, Scollo M, Naccarella L. Randomised controlled trial of three approaches for marketing smoking cessation programmes to Australian general practitioners. Br Med J 1992; 304: 691-694.